NEW DATA SHOW NO NEGATIVE LONG-TERM EFFECT IN COGNITIVE FUNCTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH NEUROSTAR TMS THERAPY®.
- Published in:
- 2011
- Publication type:
- Journal Article
Works matching IS 21588333 AND DT 2011 AND VI 8 AND IP 5
Results: 16
1
2
PHARMA TWO B PLANS FOR PHASE II STUDY OF FIXED DOSE COMBINATION THERAPY 'P2B001' FOR PARKINSON'S DISEASE FOLLOWING POSITIVE PHASE I STUDY RESULTS.
- Published in:
- 2011
- Publication type:
- Journal Article
3
Abraham's Wife, Katurah.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 41
- By:
- Publication type:
- Article
4
Examining the Therapeutic Relationship and Confronting Resistances in Psychodynamic Psychotherapy: A Certified Public Accountant Case.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
5
Visual Hallucinations Following a Left-sided Unilateral Tuberothalamic Artery Infarction.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
6
Can Tactile Sensory Processing Differentiate Between Children with Autistic Disorder and Asperger's Disorder?
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 25
- By:
- Publication type:
- Article
7
ASSESSMENT OF EVERYDAY FUNCTIONING IN SCHIZOPHRENIA.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 21
- By:
- Publication type:
- Article
8
GENDER PATTERNS in Borderline Personality Disorder.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 16
- By:
- Publication type:
- Article
9
PARTIAL DISCLOSURE OF A CO-DIAGNOSIS OF BIPOLAR DISORDER IN A WOMAN WITH BORDERLINE PERSONALITY DISORDER.
- Published in:
- 2011
- By:
- Publication type:
- Letter
10
OSELTAMIVIR USE IN PSYCHIATRIC INPATIENTS TAKING CLOZAPINE: EFFECT ON NEUROPSYCHIATRIC EVENTS.
- Published in:
- 2011
- By:
- Publication type:
- Letter
11
NEW DATA SHOW NO NEGATIVE LONG-TERM EFFECT IN COGNITIVE FUNCTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH NEUROSTAR TMS THERAPY®.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 10
- Publication type:
- Article
12
REPLIGEN RECEIVES FDA APPROVAL TO INITIATE PHASE 1 CLINICAL TRIAL OF POTENTIAL TREATMENT FOR SPINAL MUSCULAR ATROPHY.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 10
- Publication type:
- Article
13
PHARMA TWO B PLANS FOR PHASE II STUDY OF FIXED DOSE COMBINATION THERAPY "P2B001" FOR PARKINSON'S DISEASE FOLLOWING POSITIVE PHASE I STUDY RESULTS.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 9
- Publication type:
- Article
14
ENVIVO ANNOUNCES POSITIVE PHASE 2B CLINICAL DATA IN SCHIZOPHRENIA.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 8
- Publication type:
- Article
15
GENENTECH SCIENTISTS REPORT ANTIBODY DELIVERY INTO BRAIN.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 8
- Publication type:
- Article
16
Editor's Message. Issue Highlights, May 2011.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 5, p. 5
- By:
- Publication type:
- Article